Latest News about Biotech
Recent news which mentions Biotech
Biotech upsizes target for pending IPO to $250M
September 12, 2024
From Business Journals
Gilead Unveils 'Remarkable Outcomes' From Late-Stage Lenacapavir Study Showing Promise In Preventing HIV Infections
September 12, 2024
From Benzinga
Aura Biosciences Touts Promising Data From Eye Cancer Candidate
September 12, 2024
From Benzinga
GSK Reveals 'Positive' Data From Mid-Stage Study Of Seasonal Influenza mRNA Vaccine
September 12, 2024
From Benzinga
Fulcrum Therapeutics Suspends Rare Muscular Disease Candidate After Disappointing Data From Pivotal Trial
September 12, 2024
From Benzinga
Moderna Outlines Post-Covid Roadmap, Cuts Research Budget, Forecasts 2025 Sales Below Expectations
September 12, 2024
From Benzinga
From Benzinga
Want Organic Cannabis? Operators Are Turning To This Tech To Save Millions And Get Certified
September 11, 2024
From Benzinga
ADHD Drug Maker Supernus Pharmaceuticals Downgraded On Slower Prescription Growth For Its Top-Selling Drug
September 11, 2024
From Benzinga
Sony Music-Universal Music JV Hits Johnson & Johnson With Copyright Lawsuit Over Unlicensed Music Use Covering 80 Videos
September 11, 2024
From Benzinga
Viking Therapeutics Stock Could Soar 45% Ahead Of Key Weight Loss Drug Readout: JPMorgan
September 11, 2024
Tickers
VKTX
From Benzinga
From Benzinga
GSK Halts Herpes Simplex Virus Vaccine Development, Clears Path For Other Contenders Like Moderna, BioNTech
September 11, 2024
From Benzinga
Why Is Breast Cancer-Focused BriaCell Therapeutics Stock Trading Over 100% On Wednesday
September 11, 2024
From Benzinga
Sanofi, Regeneron Drug Dupixent Shows Successful Treatment Of Patients With Inflammatory Skin Disease
September 11, 2024
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.